Mangalam Drugs & Organics

quarterly
yearly
ParticularsDec '21Mar '22Jun '22Sep '22Dec '22
Revenue93.84138.25109.49108.3363.33
Expenses90.24113.44101.72102.6559.74
EBITDA3.6024.817.775.683.59
EBIT0.9322.125.172.920.71
Profit Before Tax8.954.984.243.120.50
Net Profit4.026.693.002.230.43
Financial Ratios
Operating Profit Margin3.84%17.95%7.11%5.24%5.67%
Net Profit Margin4.28%4.84%2.74%2.06%0.68%
Earning Per Share (Diluted)2.544.231.921.410.27
Dividends Per ShareNANANANANA
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.7.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI